vs
Side-by-side financial comparison of Bio-Techne (TECH) and Westrock Coffee Co (WEST). Click either name above to swap in a different company.
Westrock Coffee Co is the larger business by last-quarter revenue ($339.5M vs $295.9M, roughly 1.1× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -6.6%, a 19.5% gap on every dollar of revenue. On growth, Westrock Coffee Co posted the faster year-over-year revenue change (48.3% vs -6.4%). Over the past eight quarters, Westrock Coffee Co's revenue compounded faster (32.8% CAGR vs 4.2%).
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Westrock Coffee Co is a global integrated coffee, tea and functional beverage solutions provider. It sources, roasts, manufactures and distributes coffee products, ready-to-drink beverages and custom formulations for retail, foodservice and commercial clients across North America and other key markets.
TECH vs WEST — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $339.5M |
| Net Profit | $38.0M | $-22.6M |
| Gross Margin | 64.6% | 11.5% |
| Operating Margin | 18.4% | -2.6% |
| Net Margin | 12.8% | -6.6% |
| Revenue YoY | -6.4% | 48.3% |
| Net Profit YoY | 68.3% | 8.3% |
| EPS (diluted) | $0.24 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $295.9M | $339.5M | ||
| Q3 25 | — | $354.8M | ||
| Q2 25 | $317.0M | $280.9M | ||
| Q1 25 | $316.2M | $213.8M | ||
| Q4 24 | $297.0M | $229.0M | ||
| Q3 24 | $289.5M | $220.9M | ||
| Q2 24 | $306.1M | $208.4M | ||
| Q1 24 | $303.4M | $192.5M |
| Q4 25 | $38.0M | $-22.6M | ||
| Q3 25 | — | $-19.1M | ||
| Q2 25 | $-17.7M | $-21.6M | ||
| Q1 25 | $22.6M | $-27.2M | ||
| Q4 24 | $34.9M | $-24.6M | ||
| Q3 24 | $33.6M | $-14.3M | ||
| Q2 24 | $40.6M | $-17.8M | ||
| Q1 24 | $49.1M | $-23.7M |
| Q4 25 | 64.6% | 11.5% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | 62.7% | 14.7% | ||
| Q1 25 | 67.9% | 13.6% | ||
| Q4 24 | 65.3% | 16.6% | ||
| Q3 24 | 63.2% | 16.8% | ||
| Q2 24 | 66.4% | 19.9% | ||
| Q1 24 | 67.4% | 19.4% |
| Q4 25 | 18.4% | -2.6% | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | -7.5% | -5.3% | ||
| Q1 25 | 12.2% | -6.1% | ||
| Q4 24 | 16.0% | -4.3% | ||
| Q3 24 | 13.8% | -5.8% | ||
| Q2 24 | 15.0% | -7.9% | ||
| Q1 24 | 22.1% | -5.3% |
| Q4 25 | 12.8% | -6.6% | ||
| Q3 25 | — | -5.4% | ||
| Q2 25 | -5.6% | -7.7% | ||
| Q1 25 | 7.1% | -12.7% | ||
| Q4 24 | 11.7% | -10.7% | ||
| Q3 24 | 11.6% | -6.5% | ||
| Q2 24 | 13.3% | -8.5% | ||
| Q1 24 | 16.2% | -12.3% |
| Q4 25 | $0.24 | $-0.22 | ||
| Q3 25 | — | $-0.20 | ||
| Q2 25 | $-0.11 | $-0.23 | ||
| Q1 25 | $0.14 | $-0.29 | ||
| Q4 24 | $0.22 | $-0.26 | ||
| Q3 24 | $0.21 | $-0.16 | ||
| Q2 24 | $0.26 | $-0.20 | ||
| Q1 24 | $0.31 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $172.9M | $49.9M |
| Total DebtLower is stronger | $260.0M | $444.1M |
| Stockholders' EquityBook value | $2.0B | $-1.9M |
| Total Assets | $2.5B | $1.2B |
| Debt / EquityLower = less leverage | 0.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $172.9M | $49.9M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | $162.2M | $44.0M | ||
| Q1 25 | $140.7M | $33.1M | ||
| Q4 24 | $177.5M | $26.2M | ||
| Q3 24 | $187.5M | $22.4M | ||
| Q2 24 | $152.9M | $24.3M | ||
| Q1 24 | $145.3M | $12.6M |
| Q4 25 | $260.0M | $444.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | $346.0M | — | ||
| Q1 25 | $330.0M | — | ||
| Q4 24 | $300.0M | $393.1M | ||
| Q3 24 | $300.0M | — | ||
| Q2 24 | $319.0M | — | ||
| Q1 24 | $389.0M | — |
| Q4 25 | $2.0B | $-1.9M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | $1.9B | $18.2M | ||
| Q1 25 | $2.0B | $71.4M | ||
| Q4 24 | $2.1B | $97.5M | ||
| Q3 24 | $2.1B | $110.3M | ||
| Q2 24 | $2.1B | $81.5M | ||
| Q1 24 | $2.0B | $91.7M |
| Q4 25 | $2.5B | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $2.6B | $1.2B | ||
| Q1 25 | $2.6B | $1.1B | ||
| Q4 24 | $2.7B | $1.1B | ||
| Q3 24 | $2.7B | $1.1B | ||
| Q2 24 | $2.7B | $1.1B | ||
| Q1 24 | $2.7B | $983.3M |
| Q4 25 | 0.13× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.14× | 4.03× | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $36.7M |
| Free Cash FlowOCF − Capex | — | $27.8M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | — | 2.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $36.7M | ||
| Q3 25 | — | $-26.6M | ||
| Q2 25 | $98.2M | $-7.0M | ||
| Q1 25 | $41.1M | $-22.1M | ||
| Q4 24 | $84.3M | $2.8M | ||
| Q3 24 | $63.9M | $-332.0K | ||
| Q2 24 | $75.5M | $-23.7M | ||
| Q1 24 | $81.0M | $8.0M |
| Q4 25 | — | $27.8M | ||
| Q3 25 | — | $-44.7M | ||
| Q2 25 | $93.3M | $-27.5M | ||
| Q1 25 | $31.0M | $-63.4M | ||
| Q4 24 | $77.5M | $-15.4M | ||
| Q3 24 | $54.7M | $-36.7M | ||
| Q2 24 | $57.5M | $-59.9M | ||
| Q1 24 | $64.5M | $-60.9M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | -12.6% | ||
| Q2 25 | 29.4% | -9.8% | ||
| Q1 25 | 9.8% | -29.7% | ||
| Q4 24 | 26.1% | -6.7% | ||
| Q3 24 | 18.9% | -16.6% | ||
| Q2 24 | 18.8% | -28.7% | ||
| Q1 24 | 21.3% | -31.7% |
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | 1.5% | 7.3% | ||
| Q1 25 | 3.2% | 19.3% | ||
| Q4 24 | 2.3% | 7.9% | ||
| Q3 24 | 3.2% | 16.5% | ||
| Q2 24 | 5.9% | 17.4% | ||
| Q1 24 | 5.4% | 35.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.82× | — | ||
| Q4 24 | 2.42× | — | ||
| Q3 24 | 1.90× | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 1.65× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
